TD Cowen raised the firm’s price target on Cellebrite to $23 from $20 and keeps a Buy rating on the shares. The firm met with management and came away viewing Celle, sees the company leveraging automation, ML, and AI to extend competitive positioning in a market it already leads , and True Wind’s recent 19% ownership in Suncorp could unlock long term value.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLBT:
- Cellebrite DI Shareholders Approve All Proposals
- Cellebrite Completes Warrant Redemption Process
- Cellebrite Announces Results of Completed Redemption of All Outstanding Warrants
- Cellebrite enhance investigative analytics solution with AWS
- Cellebrite Enhances Investigative Analytics Solution with Amazon Web Services (AWS)